Journal article 651 views
Hyperfractionated Accelerated Radiotherapy (HART) with maintenance chemotherapy for metastatic (M1–3) Medulloblastoma – A safety/feasibility study
Roger Taylor 
,
Andrew J. Howman,
Keith Wheatley,
Elena E. Brogden,
Bridget Large,
Michael J. Gibson,
Keith Robson,
Dipayan Mitra,
Frank Saran,
Antony Michalski,
Barry L. Pizer
,
Andrew J. Howman,
Keith Wheatley,
Elena E. Brogden,
Bridget Large,
Michael J. Gibson,
Keith Robson,
Dipayan Mitra,
Frank Saran,
Antony Michalski,
Barry L. Pizer
Radiotherapy and Oncology, Volume: 111, Issue: 1, Pages: 41 - 46
Swansea University Author:
Roger Taylor
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1016/j.radonc.2014.01.022
Abstract
Hyperfractionated Accelerated Radiotherapy (HART) with maintenance chemotherapy for metastatic (M1–3) Medulloblastoma – A safety/feasibility study
| Published in: | Radiotherapy and Oncology |
|---|---|
| ISSN: | 01678140 |
| Published: |
2014
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa36283 |
| first_indexed |
2017-10-26T19:06:13Z |
|---|---|
| last_indexed |
2018-02-09T05:28:23Z |
| id |
cronfa36283 |
| recordtype |
SURis |
| fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2018-02-08T14:33:03.4880186</datestamp><bib-version>v2</bib-version><id>36283</id><entry>2017-10-26</entry><title>Hyperfractionated Accelerated Radiotherapy (HART) with maintenance chemotherapy for metastatic (M1–3) Medulloblastoma – A safety/feasibility study</title><swanseaauthors><author><sid>fe6f87c187a81cc4c879d8eeff23d21a</sid><ORCID>0000-0002-2537-7651</ORCID><firstname>Roger</firstname><surname>Taylor</surname><name>Roger Taylor</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2017-10-26</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Radiotherapy and Oncology</journal><volume>111</volume><journalNumber>1</journalNumber><paginationStart>41</paginationStart><paginationEnd>46</paginationEnd><publisher/><issnPrint>01678140</issnPrint><keywords>Chemotherapy; HART; Medulloblastoma; Metastatic</keywords><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2014</publishedYear><publishedDate>2014-12-31</publishedDate><doi>10.1016/j.radonc.2014.01.022</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2018-02-08T14:33:03.4880186</lastEdited><Created>2017-10-26T13:46:55.8254671</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Roger</firstname><surname>Taylor</surname><orcid>0000-0002-2537-7651</orcid><order>1</order></author><author><firstname>Andrew J.</firstname><surname>Howman</surname><order>2</order></author><author><firstname>Keith</firstname><surname>Wheatley</surname><order>3</order></author><author><firstname>Elena E.</firstname><surname>Brogden</surname><order>4</order></author><author><firstname>Bridget</firstname><surname>Large</surname><order>5</order></author><author><firstname>Michael J.</firstname><surname>Gibson</surname><order>6</order></author><author><firstname>Keith</firstname><surname>Robson</surname><order>7</order></author><author><firstname>Dipayan</firstname><surname>Mitra</surname><order>8</order></author><author><firstname>Frank</firstname><surname>Saran</surname><order>9</order></author><author><firstname>Antony</firstname><surname>Michalski</surname><order>10</order></author><author><firstname>Barry L.</firstname><surname>Pizer</surname><order>11</order></author></authors><documents/><OutputDurs/></rfc1807> |
| spelling |
2018-02-08T14:33:03.4880186 v2 36283 2017-10-26 Hyperfractionated Accelerated Radiotherapy (HART) with maintenance chemotherapy for metastatic (M1–3) Medulloblastoma – A safety/feasibility study fe6f87c187a81cc4c879d8eeff23d21a 0000-0002-2537-7651 Roger Taylor Roger Taylor true false 2017-10-26 MEDS Journal Article Radiotherapy and Oncology 111 1 41 46 01678140 Chemotherapy; HART; Medulloblastoma; Metastatic 31 12 2014 2014-12-31 10.1016/j.radonc.2014.01.022 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2018-02-08T14:33:03.4880186 2017-10-26T13:46:55.8254671 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Roger Taylor 0000-0002-2537-7651 1 Andrew J. Howman 2 Keith Wheatley 3 Elena E. Brogden 4 Bridget Large 5 Michael J. Gibson 6 Keith Robson 7 Dipayan Mitra 8 Frank Saran 9 Antony Michalski 10 Barry L. Pizer 11 |
| title |
Hyperfractionated Accelerated Radiotherapy (HART) with maintenance chemotherapy for metastatic (M1–3) Medulloblastoma – A safety/feasibility study |
| spellingShingle |
Hyperfractionated Accelerated Radiotherapy (HART) with maintenance chemotherapy for metastatic (M1–3) Medulloblastoma – A safety/feasibility study Roger Taylor |
| title_short |
Hyperfractionated Accelerated Radiotherapy (HART) with maintenance chemotherapy for metastatic (M1–3) Medulloblastoma – A safety/feasibility study |
| title_full |
Hyperfractionated Accelerated Radiotherapy (HART) with maintenance chemotherapy for metastatic (M1–3) Medulloblastoma – A safety/feasibility study |
| title_fullStr |
Hyperfractionated Accelerated Radiotherapy (HART) with maintenance chemotherapy for metastatic (M1–3) Medulloblastoma – A safety/feasibility study |
| title_full_unstemmed |
Hyperfractionated Accelerated Radiotherapy (HART) with maintenance chemotherapy for metastatic (M1–3) Medulloblastoma – A safety/feasibility study |
| title_sort |
Hyperfractionated Accelerated Radiotherapy (HART) with maintenance chemotherapy for metastatic (M1–3) Medulloblastoma – A safety/feasibility study |
| author_id_str_mv |
fe6f87c187a81cc4c879d8eeff23d21a |
| author_id_fullname_str_mv |
fe6f87c187a81cc4c879d8eeff23d21a_***_Roger Taylor |
| author |
Roger Taylor |
| author2 |
Roger Taylor Andrew J. Howman Keith Wheatley Elena E. Brogden Bridget Large Michael J. Gibson Keith Robson Dipayan Mitra Frank Saran Antony Michalski Barry L. Pizer |
| format |
Journal article |
| container_title |
Radiotherapy and Oncology |
| container_volume |
111 |
| container_issue |
1 |
| container_start_page |
41 |
| publishDate |
2014 |
| institution |
Swansea University |
| issn |
01678140 |
| doi_str_mv |
10.1016/j.radonc.2014.01.022 |
| college_str |
Faculty of Medicine, Health and Life Sciences |
| hierarchytype |
|
| hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
| hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
| department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
| document_store_str |
0 |
| active_str |
0 |
| published_date |
2014-12-31T01:29:17Z |
| _version_ |
1822001209546899456 |
| score |
11.048042 |